Compile Data Set for Download or QSAR
Report error Found 670 Enz. Inhib. hit(s) with all data for entry = 10788
LigandPNGBDBM569186(US11427558, Example 333)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM569185(US11427558, Example 332)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM569188(US11427558, Example 335)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM569187(US11427558, Example 334)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM569188(US11427558, Example 335)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568858(US11427558, Example 5)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568859(US11427558, Example 6)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568857(US11427558, Example 4)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568858(US11427558, Example 5)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568860(US11427558, Example 7)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568859(US11427558, Example 6)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568860(US11427558, Example 7)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568862(US11427558, Example 9)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568863(US11427558, Example 10)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568861(US11427558, Example 8)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568864(US11427558, Example 11)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568863(US11427558, Example 10)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568854(US11427558, Example 1)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568855(US11427558, Example 2)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568854(US11427558, Example 1)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568856(US11427558, Example 3)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568857(US11427558, Example 4)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568855(US11427558, Example 2)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568856(US11427558, Example 3)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568874(US11427558, Example 21)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568875(US11427558, Example 22)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568873(US11427558, Example 20)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568874(US11427558, Example 21)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568876(US11427558, Example 23)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568875(US11427558, Example 22)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568880(US11427558, Example 27)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568879(US11427558, Example 26)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568866(US11427558, Example 13)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568865(US11427558, Example 12)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568868(US11427558, Example 15)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568867(US11427558, Example 14)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568870(US11427558, Example 17)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568871(US11427558, Example 18)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568869(US11427558, Example 16)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568870(US11427558, Example 17)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568872(US11427558, Example 19)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568871(US11427558, Example 18)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568872(US11427558, Example 19)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568890(US11427558, Example 37)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568889(US11427558, Example 36)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568891(US11427558, Example 38)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568894(US11427558, Example 41)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568893(US11427558, Example 40)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568896(US11427558, Example 43)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

LigandPNGBDBM568897(US11427558, Example 44)
Affinity DataIC50: 100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
US Patent

Displayed 1 to 50 (of 670 total ) | Next | Last >>
Jump to: